Table: Daito Pharmaceutical -Q1 group results

Daito Pharmaceutical

14/10/2026 07:30

Oct 14 (Reuters)-
Daito Pharmaceutical
CONSOLIDATED FINANCIAL HIGHLIGHTS

 (in billions of yen unless specified)

            3 months ended  3 months ended    Year to
            Aug 31, 2026    Aug 31, 2025   May 31, 2027
               LATEST         YEAR-AGO        LATEST
              RESULTS         RESULTS        FORECAST
Sales          11.89           13.01          54.00
             (-8.6 pct)      (+2.6 pct)     (+6.6 pct)
Operating     712 mln         998 mln          4.00
            (-28.7 pct)     (+17.6 pct)    (+10.0 pct)
Recurring     808 mln           1.05           4.00
            (-23.2 pct)      (+7.1 pct)     (+4.9 pct)
Net           700 mln         696 mln          3.00
             (+0.6 pct)     (+12.8 pct)     (-5.1 pct)
EPS          24.66 yen       23.24 yen      104.37 yen
Ann Div          --          40.00 yen      45.00 yen
-Q2 div          --          20.00 yen      22.50 yen
-Q4 div          --          20.00 yen      22.50 yen


 NOTE - Daito Pharmaceutical.

To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T